• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Added value of Joint ENT-Rheumatology clinic in the management of ANCA-associated vasculitis: One year's experience.

作者信息

Stavrakas M, Smith R, Akil M, Kuet K-P, Morley F, Ray J

机构信息

ENT Department, Sheffield Teaching Hospitals NHS Trust, Sheffield, UK.

Rheumatology Department, Sheffield Teaching Hospitals NHS Trust, Sheffield, UK.

出版信息

Am J Otolaryngol. 2022 Jul-Aug;43(4):103485. doi: 10.1016/j.amjoto.2022.103485. Epub 2022 May 5.

DOI:10.1016/j.amjoto.2022.103485
PMID:35567837
Abstract

PURPOSE

ANCA-associated vasculitides (AAV) represent a group of diagnoses, including granulomatosis with polyangiitis (GPA), eosinophilic granulomatosis with polyangiitis (EGPA) and microscopic polyangiitis (MPA). Most commonly, they present initially with ENT-associated symptomatology, and therefore they often pose a diagnostic challenge. We aim to present our one-year experience in the joint management of AAV in a multi-disciplinary setting.

METHODS

We performed a retrospective analysis based on the records of 39 patients who were seen in the joint clinic, during a period of one year.

RESULTS

After clinical assessment, 13 patients had changes made to their ENT treatment, 2 had some changes in their immunosuppression, while 11 had changes in both ENT and Rheumatology treatment. Six patients did not require any alterations to their therapeutic scheme. On average three separate appointments were reduced to a single appointment in the joint clinic where definitive treatment decisions were made. This led to significant cost reductions.

CONCLUSIONS

Cost-effectiveness, patient satisfaction, rapid multi-disciplinary evaluation, avoidance of unnecessary immunosuppression, patient education and medical training are only a few of the many advantages of this proposed joint service.

摘要

相似文献

1
Added value of Joint ENT-Rheumatology clinic in the management of ANCA-associated vasculitis: One year's experience.
Am J Otolaryngol. 2022 Jul-Aug;43(4):103485. doi: 10.1016/j.amjoto.2022.103485. Epub 2022 May 5.
2
[Recommendations on the diagnosis and treatment of anti-neutrophil cytoplasmic antibody associated vasculitis in China].《中国抗中性粒细胞胞浆抗体相关性血管炎诊断和治疗推荐》
Zhonghua Nei Ke Za Zhi. 2022 Oct 1;61(10):1128-1135. doi: 10.3760/cma.j.cn112138-20220318-00191.
3
The utility of the ACR/EULAR 2017 provisional classification criteria for granulomatosis with polyangiitis in Korean patients with antineutrophil cytoplasmic antibody-associated vasculitis.ACR/EULAR 2017 年临时性分类标准在韩国抗中性粒细胞胞浆抗体相关性血管炎患者中对肉芽肿伴多血管炎的实用性。
Clin Exp Rheumatol. 2018 Mar-Apr;36 Suppl 111(2):85-87. Epub 2017 Nov 27.
4
Cutaneous manifestations of antineutrophil cytoplasmic antibody-associated vasculitis (AAV): a concise review with emphasis on clinical and histopathologic correlation.抗中性粒细胞胞质抗体相关性血管炎(AAV)的皮肤表现:简要综述,重点为临床与组织病理相关性。
Int J Dermatol. 2022 Dec;61(12):1442-1451. doi: 10.1111/ijd.16247. Epub 2022 May 22.
5
Comparison of the 2022 ACR/EULAR Classification Criteria for Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Previous Criteria.抗中性粒细胞胞浆抗体相关性血管炎 2022ACR/EULAR 分类标准与既往标准的比较。
Yonsei Med J. 2023 Jan;64(1):11-17. doi: 10.3349/ymj.2022.0435.
6
Evaluation of Ministry of Health, Labour and Welfare diagnostic criteria for antineutrophil cytoplasmic antibody-associated vasculitis compared to ACR/EULAR 2022 classification criteria.卫生部、劳工和福利评估抗中性粒细胞胞浆抗体相关性血管炎的诊断标准与 ACR/EULAR 2022 分类标准的比较。
Mod Rheumatol. 2024 Mar 28;34(3):551-558. doi: 10.1093/mr/road052.
7
The Reclassification of Patients With Previously Diagnosed Eosinophilic Granulomatosis With Polyangiitis Based on the 2022 ACR/EULAR Criteria for Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.基于2022年美国风湿病学会/欧洲抗风湿病联盟抗中性粒细胞胞浆抗体相关血管炎标准对先前诊断为嗜酸性肉芽肿性多血管炎患者的重新分类
J Rheumatol. 2023 Feb;50(2):213-218. doi: 10.3899/jrheum.220560. Epub 2022 Sep 15.
8
[Granulomatous vasculitides and vasculitides with extravascular granulomatosis].[肉芽肿性血管炎及伴有血管外肉芽肿形成的血管炎]
Z Rheumatol. 2022 Sep;81(7):558-566. doi: 10.1007/s00393-022-01249-7. Epub 2022 Aug 12.
9
Systematic literature review informing the 2022 update of the EULAR recommendations for the management of ANCA-associated vasculitis (AAV): Part 2 - Treatment of eosinophilic granulomatosis with polyangiitis and diagnosis and general management of AAV.系统文献回顾为 2022 年更新 EULAR 关于抗中性粒细胞胞浆抗体相关性血管炎(AAV)管理的建议提供信息:第 2 部分 - 嗜酸性肉芽肿性多血管炎的治疗和 AAV 的诊断与一般管理。
RMD Open. 2023 Jun;9(2). doi: 10.1136/rmdopen-2023-003083.
10
How to improve the histopathological diagnosis of systemic vasculitides in daily practice?如何在日常实践中提高系统性血管炎的组织病理学诊断水平?
Cesk Patol. 2020 Spring;56(2):68-73.

引用本文的文献

1
The 2025 British Society for Rheumatology management recommendations for ANCA-associated vasculitis.2025年英国风湿病学会抗中性粒细胞胞浆抗体相关性血管炎管理建议
Rheumatology (Oxford). 2025 Aug 1;64(8):4470-4494. doi: 10.1093/rheumatology/keaf240.
2
Scoping Review of Economic Analyses of Rare Kidney Diseases.罕见肾病经济分析的范围综述
Kidney Int Rep. 2024 Sep 12;9(12):3553-3569. doi: 10.1016/j.ekir.2024.09.004. eCollection 2024 Dec.